FDA Inspection 785250 — AstraZeneca UK Ltd.

AstraZeneca UK Ltd. — FEI 3002850317

The FDA completed an inspection of AstraZeneca UK Ltd. on Mar 16, 2012 in Macclesfield. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 16, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Macclesfield (United Kingdom)

Citations

IDCFRDescription
145121 CFR 211.113(b)Procedures for sterile drug products
440221 CFR 211.192Written record of investigation incomplete

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.